NCT07176689View on ClinicalTrials.gov

Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)

PHASE4RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

February 28, 2031

Study Completion Date

March 30, 2031

Conditions
Desmoid TumorAggressive Fibromatosis
Interventions
DRUG

Nirogacestat

Nirogacestat oral tablet

Trial Locations (1)

NW1 2PG

RECRUITING

University College London Hospitals NHS Foundation Trust, London

All Listed Sponsors
lead

SpringWorks Therapeutics, Inc.

INDUSTRY

NCT07176689 - Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF) | Biotech Hunter | Biotech Hunter